Molecular Docking and ADMET Profiling of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin from Dalbergia Sissoo: In Silico Prediction in Antidiabetic Potential. Int. J. Pharm. Sci. Drug Res. 2024, 16 (5), 841-854. https://doi.org/10.25004/IJPSDR.2024.160512.